Nuzenio

Neurocrine

Neurocrine news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 12 publisher sources 100/100 entity strength

Latest news

Timeline

Sat, 08 Aug 2026 06:26:15 GMTHow Stronger Q2 Results and New Equity Capacity Will Impact Neurocrine Biosciences (NBIX) Investors - simplywall.st
Fri, 07 Aug 2026 17:19:41 GMTNeurocrine Biosciences Begins Phase 1 Study of GLP-1/GIP/Glucagon Triple Agonist NBIP-'1968 for Obesity - BioPharm International
Fri, 07 Aug 2026 16:26:00 GMTNeurocrine advances GLP-1/GIP/glucagon triple agonist into first-in-human obesity study - AllSci
Fri, 07 Aug 2026 12:49:32 GMTNeurocrine starts Phase 1 trial for new obesity drug NBIP-'1968 targeting multiple metabolic pathways. - Pluang
Fri, 07 Aug 2026 10:55:54 GMTNeurocrine Biosciences, Inc. $NBIX Stake Boosted by PKO BP BANKOWY Universal Pension Society JSC - MarketBeat
Thu, 06 Aug 2026 01:53:30 GMTNeurocrine Biosciences, Inc. (NBIX) Stock Forecasts - Yahoo Finance

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Neurocrine.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

12 distinct publisher/source names are currently connected to this entity page.